(PharmaNewsWire.Com, February 02, 2017 ) The global autoimmune disease diagnostics market expected to witness robust growth owning to increased prevalence of autoimmune disease. According to the American Autoimmune Related Diseases Association (AARDA), 50 million Americans are living with autoimmune disease. Discoveries in diagnostic techniques in autoimmune disease, increasing public awareness for autoimmune disorders, upgraded laboratory techniques and automation are the major driving factors for the market growth. The novel technologies such as portable devices and novel biomarkers are anticipated to drive market growth. The key restraints for this market include intense competitive pricing among manufacturers, growing demand for innovative technological products and unavailability of skilled manpower are hampering the autoimmune disease diagnostics market.
Autoimmune Disease is a condition where patients’ immune system attacks own body tissue or system that led to destruction of the body organs. Around 80 types of autoimmune diseases are known so far. The blood cells in our body’s immune system help defend against injurious substances. Examples of these injurious substances include viruses, bacteria, cancer cells, toxins and blood and tissue which are external to the body. These substances contain antigens. The body’s immune system produces antibodies to counter these antigens substances that enable it to abolish these harmful substances. Patient with autoimmune disorder does not differentiate between own tissue and antigens. As a result, body produces reaction that destroys normal tissues. Autoimmune disease diagnostics is done to evaluate the disease condition along with its stage and type, so that treatment can be done effectively. Autoimmune Disease Diagnostics Market is growing positively owing to increased prevalence of disease, improved awareness among key stake holders in the market.
Global autoimmune disease diagnostics market is expected to show significant growth due to the mergers & acquisition between the companies and research institutes. Moreover, with the introduction of new technologies and services in the given market which is expected to increase point of care (POC) tests which may change the market dynamics over a given period of forecast. Based on the disease type, segments such as systemic autoimmune diagnostics in global autoimmune disease diagnostics market is expected to grow positively owing to increasing occurrences of these diseases.
Geographically, global autoimmune disease diagnostics market is classified into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is demonstrating increased incidence of autoimmune disorder because of change in lifestyle, unhealthy eating and hygiene. NIH estimates up to 23.5 million Americans have an autoimmune disease. In comparison, cancer affects up to 9 million and heart disease up to 22 million. Furthermore, availability of vast unexploited opportunities in the growing European countries is expected to strengthen growth over the forecasted period. Despite of having lower prevalence and incidence rate, market size of Asia pacific is considerable because of its sizable population.
Some of the major players in the global Autoimmune Disease Diagnostics Market include Bio-Rad, Siemens Healthcare, Roche Diagnostics SQI Diagnostics, Abbott Laboratories, AESKU Diagnostics, Beckman Coulter Inc., INOVA Diagnostics Inc., BioMerieux SA, Crescendo Bioscience, and Hemagen Diagnostics, Quest Diagnostics.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: